Financial report interval: 2025.12.31 - 2026.03.31
Preview: Verastem(VSTM) predict that the Revenue is 18.67 M (--%), Miss estimate;the EBIT is -44.9 M (-1.64%), Miss estimate;the EPS is -0.37 (+61.46%), Beat estimate.